Cerebellum’s Nutanix NTNX Stock Holding History

Cerebellum’s Portfolio NTNX Stock Details NTNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,089	Closed	-$170K	–	520
2018 Q4	$170K	Sell	4,089 -302	-7%	-$12.5K	0.12%	322
2018 Q3	$188K	Buy	+4,391	New	+$232K	0.3%	88

Other funds holding NTNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cerebellum's NTNX Position: Q1 2019 in Review

Cerebellum sold out of Nutanix (NTNX) in Q1 2019, closing a stake of 4,089 shares — an estimated $170K sold.

Cerebellum first reported a position in NTNX in Q3 2018 and held it in 2 quarters. The position peaked at $188K in Q3 2018. 321 funds tracked by Wall St. Rank hold NTNX as of Q1 2019.

Cerebellum reported no remaining Nutanix position as of Q1 2019 after selling out during the quarter.
Cerebellum sold 4,089 Nutanix shares in Q1 2019, an estimated $170K.
Cerebellum first reported a position in Nutanix in Q3 2018 and held it in 2 quarters.
Cerebellum's Nutanix position peaked at $188K in Q3 2018.
321 funds tracked by Wall St. Rank held Nutanix as of Q1 2019.

Based on Cerebellum's 13F filing for Q1 2019, filed 21 May 2019.